EBF1 is a potential biomarker for predicting progression from mild cognitive impairment to Alzheimer's disease: an in silico study
EBF1, as a B cell-specific transcription factor, may be a key target for predicting progression from MCI to AD. Our nomogram model was able to provide personalized risk factors for the progression from MCI to AD after evaluation and validation.
Authors
- Yanxiu Ju
- Qing Zhao (ORCID: https://orcid.org/0000-0003-2250-5571)
- Xiangyi Kong (ORCID: https://orcid.org/0000-0002-8209-042X)
- Songtao Li (ORCID: https://orcid.org/0000-0002-2926-673X)
Institutions
- Union Hospital (HK)
- Jilin University (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Frontiers in Aging Neuroscience
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3389/fnagi.2024.1397696
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- People's Government of Jilin Province
- Department of Science and Technology of Jilin Province